Tersigni Vision is drawing attention to a critical credential that sets its founder, Dr. Steven Tersigni, apart in the field ...
Samsara Vision Announces First Pseudophakic Surgery in the PERSPECTIVE Clinical Trial to evaluate SING IMT in Patients with ...
Are you itching to catch presentations from the Ophthalmology Times® editorial advisory board? Twenty of our esteemed ...
Yunqi Capital Limited (together with its affiliates and the funds it advises, "Yunqi Capital"), an investment management firm and 5.1% shareholder of STAAR Surgical Company ("STAAR" or the "Company") ...
Implantable biosensors and wearable technologies have the potential to enable continuous, real-time monitoring of kidney and ...
Tersigni Vision has published new guidance addressing a common concern among individuals considering vision correction: ...
Mechanical vacuum aspiration to debulk lead-associated vegetations during lead extraction appears feasible and safe and ...
Prestigious three-year multicenter clinical trial confirms revolutionary implantable lens technology achieves exceptional visual outcomes with minimal complications Dr. Jason P. Brinton of Brinton ...
Investing.com -- The pending sale of STAAR Surgical Company (NASDAQ:STAA) to Alcon Inc. (NYSE:ALC) has taken an unusual turn. In April 2024, the implantable lens maker rejected a $58-per-share ...
HOUSTON, TX – With advancing vision correction technologies, many patients find themselves facing a crucial decision: LASIK or EVO ICL. Houston LASIK & Eye, under the leadership of Dr. Amjad Khokhar, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback